NEWS IN BRIEF
This article was originally published in The Silver Sheet
New SOP on FDA guidance development
You may also be interested in...
Medtronic says it received noticeably fewer bulk orders from hospitals for cardiac rhythm management devices in its most recent fiscal quarter, but insists the outcome was not related to its decision to cancel certain large group purchasing organization contracts.
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.